Abstract: Disclosed is a data communication apparatus for non-contact data communication using electromagnetic induction. At least a portion of a conductor 5a of the loop coil antenna (5) of the data communication apparatus, adapted for non-contact data communication, exploiting electromagnetic induction, is arranged for extending along the lateral side of an enclosure (2a) for equalizing the sensitivity of the loop coil antenna (5) across both major surfaces of the enclosure (2a).

Abstract: Disclosed is a data communication apparatus for non-contact data communication using electromagnetic induction. At least a portion of a conductor 5a of the loop coil antenna (5) of the data communication apparatus, adapted for non-contact data communication, exploiting electromagnetic induction, is arranged for extending along the lateral side of an enclosure (2a) for equalizing the sensitivity of the loop coil antenna (5) across both major surfaces of the enclosure (2a).

Abstract: A cylinder head includes a carrier member 50 integrally formed with a vertical wall portion 53 for supporting a camshaft 15, 16, a tappet guide 54 for containing a tappet 24 and a tappet-lubricating oil receiving portion 51 slanted around the tappet guide 54. An operation-oil supply passage 203, 209, 210 extends in the longitudinal direction of the carrier member 50 inside the tappet guide 54.

Abstract: A valve drive mechanism includes a generally cylindrically shaped tappet assembly (24) comprising a center tappet (41 ) and a side tappet (42). The center tappet (41 ) has a circular-arcuate side walls (41c) formed with vertical side shrouds (41d) at opposite sides of each side wall (41c) which overlap and slide contact with opposite end guide walls (42h) of the side tappet (42), respectively. When the tappet assembly (24) is in an unlocked state so as to transmit rotation of the side cams (25, 27), the vertical side shroud (41d) of the center tappet (41 ) slide on the vertical side walls (42h) of the side tappet 42 so as thereby to guide slide movement of the center tappet (41) relative to the side tappet (42).

Abstract: A valve drive mechanism includes a generally cylindrically shaped tappet assembly (24) comprising a center tappet (41 ) and a side tappet (42). The center tappet (41 ) has a circular-arcuate side walls (41c) formed with vertical side shrouds (41d) at opposite sides of each side wall (41c) which overlap and slide contact with opposite end guide walls (42h) of the side tappet (42), respectively. When the tappet assembly (24) is in an unlocked state so as to transmit rotation of the side cams (25, 27), the vertical side shroud (41d) of the center tappet (41 ) slide on the vertical side walls (42h) of the side tappet 42 so as thereby to guide slide movement of the center tappet (41 ) relative to the side tappet (42).

Abstract: A cylinder head includes a carrier member 50 integrally formed with a vertical wall portion 53 for supporting a camshaft 15, 16, a tappet guide 54 for containing a tappet 24 and a tappet-lubricating oil receiving portion 51 slanted around the tappet guide 54. An operation-oil supply passage 203, 209, 210 extends in the longitudinal direction of the carrier member 50 inside the tappet guide 54.

Abstract: Disclosed are (1) a structurally novel 6,9-hemiacetal- erythromycin derivative having a hydroxyl group at at least one of the 14- and 15-positions br a salt thereof, which has an excellent gastrointestinal function promoting effect and is low in toxicity; (2) a process for preparing a 6,9-hemiacetal-erythromycin derivative having a hydroxyl group at at least one of the 14- and 15-positions or a salt thereof, which comprises reacting a 6,9-hemiacetal-erythromycin derivative or a salt thereof with an organism-derived oxidase; and (3) a gastrointestinal function promoting agent containing a 6,9-hemiacetal-erythromycin derivative having a hydroxyl group at at least one of the 14- and 15-positions or a salt thereof.

Abstract: A compound of the formula: ##STR1## wherein each of R.sup.1 and R.sup.2 is hydrogen or aliphatic acyl, A is amino which may be protected, X is an amino acid sequence consisting of 1 to 10 amino acid residues which contain at least one amino acid residue having a water-solubility enhancing group, or a salt thereof has an activity of remarkably improving hematopoietic disorder and is useful as an immuno-stimulating agent or an agent for treating thrombocytopenia.

Abstract: Disclosed are (1) a structurally novel 6,9-hemiacetal-erythromycin derivative having a hydroxyl group at at least one of the 14- and 15-positions or a salt thereof, which has an excellent gastrointestinal function promoting effect and is low in toxicity; (2) a process for preparing a 6,9-hemiacetal-erythromycin derivative having a hydroxyl group at at least one of the 14- and 15-positions or a salt thereof, which comprises reacting a 6,9-hemiacetal-erythromycin derivative or a salt thereof with an organism-derived oxidase; and (3) a gastrointestinal function promoting agent containing a 6,9-hemiacetal-erythromycin derivative having a hydroxyl group at at least one of the 14- and 15-positions or a salt thereof.

Abstract: A compound of the formula ##STR1## wherein R.sup.1 is hydrogen or a hydrocarbon residue which may be substituted; R.sup.2 is oxo or hydrogen plus hydroxy which may be acylated; R.sup.3 is hydrogen or hydroxy which may be acylated; at least one of the dotted lines represents a single bond, or a salt thereof, produced from Penicillum thomii has potent RA-89 muscarinic receptor blocking activity and is of value as therapeutic agent for parkinsonism, ulcer, etc. or as mydriatics.

Abstract: A compound having the formula (I) or (II) ##STR1## wherein R.sup.1 is a hydrogen atom or an organic residue bonded via a carbon atom, R.sup.2 is a hydrogen atom or a N-protecting group, --COR.sup.3 is an optionally esterified or amidated carboxyl group, R.sup.4 and R.sup.5 are the same or different and respectively a hydrogen atom or an acyl group or a chain or alicyclic hydrocarbon group optionally having an aryl substituent, R.sup.6 is NOH or O, n is an integer of 0 to 3, or R.sup.4 and R.sup.5 together with the adjacent nitrogen atom may form a ring or an optionally substituted benzylidene amino group, which is useful therapeutics of brain dysfunction.

Abstract: Novel antibiotics TAN-1057 represented by the formula: ##STR1## wherein, the absolute configuration at (A) is R or S; R.sub.1 is hydrogen and both R.sub.2 and R.sub.3 taken together form a chemical bond, or R.sub.3 is hydrogen and both R.sub.1 and R.sub.2 taken together form a chemical bond; were produced by microorganisms belonging to the genus Flexibacter. TAN-1057 strongly inhibit the growth of pathogenic microorganisms and malignant tumors, thus being useful as therapeutic agents of infectious diseases or antitumor agents.

Abstract: A compound of the formula: wherein R.sub.1 is hydrogen, alkyl or acyl, R.sub.2 is hydroxy, alkoxy or amino, is useful as an antidiabetic agent.

Abstract: In a V-type internal combustion engine having a pair of upwardly diverging cylinder banks and an auxiliary unit disposed at an upper portion in a space defined between the cylinder banks, a suction arrangement includes intake ports provided at an inner side of the respective cylinder banks, inclined inwardly by a predetermined angle with respect to respective clyinder axes, and extending upwardly in a generally vertical direction so as not to interfere with the auxiliary unit, and cylinder communicating portions connected to upper portions of the intake ports in communication with the respective cylinders to permit the introduction of the intake gas thereto.

Abstract: A compound of the formula ##STR1## wherein R.sup.1 and R.sup.4 are independently amino or an organic residue bonded through nitrogen, R.sup.2 is hydrogen or alkyl which may be substituted, R.sup.3 is hydrogen or a protecting group and R5 is hydroxyl which may be substituted or amino which may be substituted or salts thereof; with the proviso that when R.sup.1 is amino, leucylamino, acetylamino or benzyloxycarbonylamino, R.sup.3 is hydrogen, methyl or 2-tettrahydropyranyl, R.sup.4 is amino, acetylamino or benzyloxycarbonylamino and R.sup.5 is hydroxyl which may be substituted or amino which may be substituted, R.sup.2 is alkyl which may be substituted, has antibacterial activities against drug-resistant bacteria and therefore can be useful as a chemotherapeutic drug for bacterial infections in mammals.

Abstract: The compounds of the formula: ##STR1## wherein R.sup.1 is hydrogen, amino, isonitrile or an organic residue bonded through nitrogen; R.sup.2 is carboxy or a group derivable therefrom; X is hydrogen, methoxy, formylamino, alkyl which may be substituted, alkylthio in which the sulfur atom may be oxidized or azido, or forms a double bond together with the adjacent carbon atom; provided that when R.sup.1 is acetylamino or amino and X is hydrogen, R.sup.2 is not para-nitrobenzyloxycarbonyl or benzhydryloxycarbonyl, or a pharmaceutically acceptable salt thereof, exhibit excellent antimicrobial activity, and are utilized as antimicrobial agents.

Abstract: As the novel antibiotic TAN-950A having the structural formula ##STR1## and salt thereof of the present invention show antimicrobial action against fungi, they can be used in the therapeutics of fungal infections, in human and other animals etc. by oral, parenteral or external administration.

Abstract: The iron-containing biologically active peptide TAN-866 produced by microorganisms belonging to the genus Pseudomonas and its iron free compounds have antibacterial activity mainly against gram-negative bacteria. These peptides can be used as a therepeutic agent for bacterial infections in mammals, domestic fowl, etc., caused by Pseudomonas aeruginosa. Further, TAN-866 and its deacyl compounds are also promising as the starting materials and intermediates for the synthesis of novel products.

Abstract: Hygromycin, epihygromycin and a mixture thereof have potent inhibitory activity against Treponema hyodysenteriae and are useful for treatment of swine dysentery.

Abstract: A compound of the formula: ##STR1## wherein R.sub.1 is hydrogen, alkyl or acyl, R.sub.2 is hydroxy, alkoxy or amino, is useful as an antidiabetic agent.